カテゴリー： QYResearch, 世界, 医療/バイオ

世界の長時間作用型薬物送達市場インサイト及び予測（装置、非経口注射）

◆英語タイトル：Global Long Acting Drug Delivery Market Insights, Forecast to 2028
	◆商品コード：QY22JLX09669 ◆発行会社（リサーチ会社）：QYResearch ◆発行日：2022年7月（※2025年版があります。お問い合わせください。） ◆ページ数：108 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後3営業日） ◆調査対象地域：グローバル ◆産業分野：医療機器

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD4,900 ⇒換算￥744,800	見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）	USD7,350 ⇒換算￥1,117,200	見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）	USD9,800 ⇒換算￥1,489,600	見積依頼/購入/質問フォーム

★QYResearchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

COVID-19のパンデミックにより、長時間作用型薬物送達のグローバル市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に長時間作用型薬物送達の世界市場のxxx％を占める「装置」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「病院」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
長時間作用型薬物送達の中国市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの長時間作用型薬物送達市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

長時間作用型薬物送達のグローバル主要企業には、ViiV Healthcare、Halozyme Therapeutics、Lubrizol Life Science、Celanese Corporation、Kashiv BioSciences、4P Therapeutics、Ipsen、Midatech Pharma、Re-Vana Therapeutics、Creative Biolabsなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

長時間作用型薬物送達市場は、種類と用途によって区分されます。世界の長時間作用型薬物送達市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
装置、非経口注射

【用途別セグメント】
病院、専門クリニック、臨床研究所、その他

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- 長時間作用型薬物送達製品概要
- 種類別市場（装置、非経口注射）
- 用途別市場（病院、専門クリニック、臨床研究所、その他）
- 調査の目的
・エグゼクティブサマリー
- 世界の長時間作用型薬物送達販売量予測2017-2028
- 世界の長時間作用型薬物送達売上予測2017-2028
- 長時間作用型薬物送達の地域別販売量
- 長時間作用型薬物送達の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別長時間作用型薬物送達販売量
- 主要メーカー別長時間作用型薬物送達売上
- 主要メーカー別長時間作用型薬物送達価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（装置、非経口注射）
- 長時間作用型薬物送達の種類別販売量
- 長時間作用型薬物送達の種類別売上
- 長時間作用型薬物送達の種類別価格
・用途別市場規模（病院、専門クリニック、臨床研究所、その他）
- 長時間作用型薬物送達の用途別販売量
- 長時間作用型薬物送達の用途別売上
- 長時間作用型薬物送達の用途別価格
・北米市場
- 北米の長時間作用型薬物送達市場規模（種類別、用途別）
- 主要国別の長時間作用型薬物送達市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパの長時間作用型薬物送達市場規模（種類別、用途別）
- 主要国別の長時間作用型薬物送達市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋の長時間作用型薬物送達市場規模（種類別、用途別）
- 主要国別の長時間作用型薬物送達市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米の長時間作用型薬物送達市場規模（種類別、用途別）
- 主要国別の長時間作用型薬物送達市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカの長時間作用型薬物送達市場規模（種類別、用途別）
- 主要国別の長時間作用型薬物送達市場規模（トルコ、サウジアラビア）
・企業情報
ViiV Healthcare、Halozyme Therapeutics、Lubrizol Life Science、Celanese Corporation、Kashiv BioSciences、4P Therapeutics、Ipsen、Midatech Pharma、Re-Vana Therapeutics、Creative Biolabs
・産業チェーン及び販売チャネル分析
- 長時間作用型薬物送達の産業チェーン分析
- 長時間作用型薬物送達の原材料
- 長時間作用型薬物送達の生産プロセス
- 長時間作用型薬物送達の販売及びマーケティング
- 長時間作用型薬物送達の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- 長時間作用型薬物送達の産業動向
- 長時間作用型薬物送達のマーケットドライバー
- 長時間作用型薬物送達の課題
- 長時間作用型薬物送達の阻害要因
・主な調査結果

Long acting drug delivery systems involve slow absorption of a drug containing active pharmaceutical ingredients, which are released into the system over subsequent time. The role of long acting drug delivery systems is clinically and medically beneficial for the treatment of chronic diseases and chronic pain, as well as certain neurological disorders. Long acting drug delivery systems include injectables, implants, microarrays or micro needle patches and broadly neutralizing monoclonal antibodies. The demand of long acting drug delivery systems is largely based on their high efficiency and targeted method of drug delivery.
Market Analysis and Insights: Global Long Acting Drug Delivery Market
The global Long Acting Drug Delivery market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Device accounting for % of the Long Acting Drug Delivery global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital segment is altered to an % CAGR throughout this forecast period.
China Long Acting Drug Delivery market size is valued at US$ million in 2021, while the North America and Europe Long Acting Drug Delivery are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Long Acting Drug Delivery landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Long Acting Drug Delivery market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Long Acting Drug Delivery market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Long Acting Drug Delivery market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Long Acting Drug Delivery market.
Global Long Acting Drug Delivery Scope and Market Size
Long Acting Drug Delivery market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Long Acting Drug Delivery market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Device
Parenteral Injections
Segment by Application
Hospital
Specialty Clinics
Clinical Research Institutes
Others
By Company
ViiV Healthcare
Halozyme Therapeutics
Lubrizol Life Science
Celanese Corporation
Kashiv BioSciences
4P Therapeutics
Ipsen
Midatech Pharma
Re-Vana Therapeutics
Creative Biolabs
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

❖ レポートの目次 ❖

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Long Acting Drug Delivery Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Device
1.2.3 Parenteral Injections
1.3 Market by Application
1.3.1 Global Long Acting Drug Delivery Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Specialty Clinics
1.3.4 Clinical Research Institutes
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Long Acting Drug Delivery Market Perspective (2017-2028)
2.2 Long Acting Drug Delivery Growth Trends by Region
2.2.1 Long Acting Drug Delivery Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Long Acting Drug Delivery Historic Market Size by Region (2017-2022)
2.2.3 Long Acting Drug Delivery Forecasted Market Size by Region (2023-2028)
2.3 Long Acting Drug Delivery Market Dynamics
2.3.1 Long Acting Drug Delivery Industry Trends
2.3.2 Long Acting Drug Delivery Market Drivers
2.3.3 Long Acting Drug Delivery Market Challenges
2.3.4 Long Acting Drug Delivery Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Long Acting Drug Delivery Players by Revenue
3.1.1 Global Top Long Acting Drug Delivery Players by Revenue (2017-2022)
3.1.2 Global Long Acting Drug Delivery Revenue Market Share by Players (2017-2022)
3.2 Global Long Acting Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Long Acting Drug Delivery Revenue
3.4 Global Long Acting Drug Delivery Market Concentration Ratio
3.4.1 Global Long Acting Drug Delivery Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Long Acting Drug Delivery Revenue in 2021
3.5 Long Acting Drug Delivery Key Players Head office and Area Served
3.6 Key Players Long Acting Drug Delivery Product Solution and Service
3.7 Date of Enter into Long Acting Drug Delivery Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Long Acting Drug Delivery Breakdown Data by Type
4.1 Global Long Acting Drug Delivery Historic Market Size by Type (2017-2022)
4.2 Global Long Acting Drug Delivery Forecasted Market Size by Type (2023-2028)
5 Long Acting Drug Delivery Breakdown Data by Application
5.1 Global Long Acting Drug Delivery Historic Market Size by Application (2017-2022)
5.2 Global Long Acting Drug Delivery Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Long Acting Drug Delivery Market Size (2017-2028)
6.2 North America Long Acting Drug Delivery Market Size by Type
6.2.1 North America Long Acting Drug Delivery Market Size by Type (2017-2022)
6.2.2 North America Long Acting Drug Delivery Market Size by Type (2023-2028)
6.2.3 North America Long Acting Drug Delivery Market Share by Type (2017-2028)
6.3 North America Long Acting Drug Delivery Market Size by Application
6.3.1 North America Long Acting Drug Delivery Market Size by Application (2017-2022)
6.3.2 North America Long Acting Drug Delivery Market Size by Application (2023-2028)
6.3.3 North America Long Acting Drug Delivery Market Share by Application (2017-2028)
6.4 North America Long Acting Drug Delivery Market Size by Country
6.4.1 North America Long Acting Drug Delivery Market Size by Country (2017-2022)
6.4.2 North America Long Acting Drug Delivery Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Long Acting Drug Delivery Market Size (2017-2028)
7.2 Europe Long Acting Drug Delivery Market Size by Type
7.2.1 Europe Long Acting Drug Delivery Market Size by Type (2017-2022)
7.2.2 Europe Long Acting Drug Delivery Market Size by Type (2023-2028)
7.2.3 Europe Long Acting Drug Delivery Market Share by Type (2017-2028)
7.3 Europe Long Acting Drug Delivery Market Size by Application
7.3.1 Europe Long Acting Drug Delivery Market Size by Application (2017-2022)
7.3.2 Europe Long Acting Drug Delivery Market Size by Application (2023-2028)
7.3.3 Europe Long Acting Drug Delivery Market Share by Application (2017-2028)
7.4 Europe Long Acting Drug Delivery Market Size by Country
7.4.1 Europe Long Acting Drug Delivery Market Size by Country (2017-2022)
7.4.2 Europe Long Acting Drug Delivery Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Long Acting Drug Delivery Market Size (2017-2028)
8.2 Asia-Pacific Long Acting Drug Delivery Market Size by Type
8.2.1 Asia-Pacific Long Acting Drug Delivery Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Long Acting Drug Delivery Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Long Acting Drug Delivery Market Share by Type (2017-2028)
8.3 Asia-Pacific Long Acting Drug Delivery Market Size by Application
8.3.1 Asia-Pacific Long Acting Drug Delivery Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Long Acting Drug Delivery Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Long Acting Drug Delivery Market Share by Application (2017-2028)
8.4 Asia-Pacific Long Acting Drug Delivery Market Size by Region
8.4.1 Asia-Pacific Long Acting Drug Delivery Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Long Acting Drug Delivery Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Long Acting Drug Delivery Market Size (2017-2028)
9.2 Latin America Long Acting Drug Delivery Market Size by Type
9.2.1 Latin America Long Acting Drug Delivery Market Size by Type (2017-2022)
9.2.2 Latin America Long Acting Drug Delivery Market Size by Type (2023-2028)
9.2.3 Latin America Long Acting Drug Delivery Market Share by Type (2017-2028)
9.3 Latin America Long Acting Drug Delivery Market Size by Application
9.3.1 Latin America Long Acting Drug Delivery Market Size by Application (2017-2022)
9.3.2 Latin America Long Acting Drug Delivery Market Size by Application (2023-2028)
9.3.3 Latin America Long Acting Drug Delivery Market Share by Application (2017-2028)
9.4 Latin America Long Acting Drug Delivery Market Size by Country
9.4.1 Latin America Long Acting Drug Delivery Market Size by Country (2017-2022)
9.4.2 Latin America Long Acting Drug Delivery Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Long Acting Drug Delivery Market Size (2017-2028)
10.2 Middle East & Africa Long Acting Drug Delivery Market Size by Type
10.2.1 Middle East & Africa Long Acting Drug Delivery Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Long Acting Drug Delivery Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Long Acting Drug Delivery Market Share by Type (2017-2028)
10.3 Middle East & Africa Long Acting Drug Delivery Market Size by Application
10.3.1 Middle East & Africa Long Acting Drug Delivery Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Long Acting Drug Delivery Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Long Acting Drug Delivery Market Share by Application (2017-2028)
10.4 Middle East & Africa Long Acting Drug Delivery Market Size by Country
10.4.1 Middle East & Africa Long Acting Drug Delivery Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Long Acting Drug Delivery Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 ViiV Healthcare
11.1.1 ViiV Healthcare Company Details
11.1.2 ViiV Healthcare Business Overview
11.1.3 ViiV Healthcare Long Acting Drug Delivery Introduction
11.1.4 ViiV Healthcare Revenue in Long Acting Drug Delivery Business (2017-2022)
11.1.5 ViiV Healthcare Recent Developments
11.2 Halozyme Therapeutics
11.2.1 Halozyme Therapeutics Company Details
11.2.2 Halozyme Therapeutics Business Overview
11.2.3 Halozyme Therapeutics Long Acting Drug Delivery Introduction
11.2.4 Halozyme Therapeutics Revenue in Long Acting Drug Delivery Business (2017-2022)
11.2.5 Halozyme Therapeutics Recent Developments
11.3 Lubrizol Life Science
11.3.1 Lubrizol Life Science Company Details
11.3.2 Lubrizol Life Science Business Overview
11.3.3 Lubrizol Life Science Long Acting Drug Delivery Introduction
11.3.4 Lubrizol Life Science Revenue in Long Acting Drug Delivery Business (2017-2022)
11.3.5 Lubrizol Life Science Recent Developments
11.4 Celanese Corporation
11.4.1 Celanese Corporation Company Details
11.4.2 Celanese Corporation Business Overview
11.4.3 Celanese Corporation Long Acting Drug Delivery Introduction
11.4.4 Celanese Corporation Revenue in Long Acting Drug Delivery Business (2017-2022)
11.4.5 Celanese Corporation Recent Developments
11.5 Kashiv BioSciences
11.5.1 Kashiv BioSciences Company Details
11.5.2 Kashiv BioSciences Business Overview
11.5.3 Kashiv BioSciences Long Acting Drug Delivery Introduction
11.5.4 Kashiv BioSciences Revenue in Long Acting Drug Delivery Business (2017-2022)
11.5.5 Kashiv BioSciences Recent Developments
11.6 4P Therapeutics
11.6.1 4P Therapeutics Company Details
11.6.2 4P Therapeutics Business Overview
11.6.3 4P Therapeutics Long Acting Drug Delivery Introduction
11.6.4 4P Therapeutics Revenue in Long Acting Drug Delivery Business (2017-2022)
11.6.5 4P Therapeutics Recent Developments
11.7 Ipsen
11.7.1 Ipsen Company Details
11.7.2 Ipsen Business Overview
11.7.3 Ipsen Long Acting Drug Delivery Introduction
11.7.4 Ipsen Revenue in Long Acting Drug Delivery Business (2017-2022)
11.7.5 Ipsen Recent Developments
11.8 Midatech Pharma
11.8.1 Midatech Pharma Company Details
11.8.2 Midatech Pharma Business Overview
11.8.3 Midatech Pharma Long Acting Drug Delivery Introduction
11.8.4 Midatech Pharma Revenue in Long Acting Drug Delivery Business (2017-2022)
11.8.5 Midatech Pharma Recent Developments
11.9 Re-Vana Therapeutics
11.9.1 Re-Vana Therapeutics Company Details
11.9.2 Re-Vana Therapeutics Business Overview
11.9.3 Re-Vana Therapeutics Long Acting Drug Delivery Introduction
11.9.4 Re-Vana Therapeutics Revenue in Long Acting Drug Delivery Business (2017-2022)
11.9.5 Re-Vana Therapeutics Recent Developments
11.10 Creative Biolabs
11.10.1 Creative Biolabs Company Details
11.10.2 Creative Biolabs Business Overview
11.10.3 Creative Biolabs Long Acting Drug Delivery Introduction
11.10.4 Creative Biolabs Revenue in Long Acting Drug Delivery Business (2017-2022)
11.10.5 Creative Biolabs Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の長時間作用型薬物送達市場インサイト及び予測（装置、非経口注射）(Global Long Acting Drug Delivery Market Insights, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

世界の長時間作用型薬物送達市場インサイト及び予測（装置、非経口注射）

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp